Novaliq Announces FDA Approval of VEVYE (Cyclosporine Ophthalmic Solution) 0.1% for the Treatment of the

Logo BenzingaBenzinga
2023-06-08 13:23:00  • 10 mins

VEVYE is the first and only cyclosporine solution indicated for the treatment of signs and symptoms of dry eye disease with efficacy demonstrated after 4 weeks

Novaliq GmbH, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has approved VEVYE (cyclosporine ophthalmic solution) 0.1% for the treatment of the signs and symptoms of dry eye disease. VEVYE (development name CyclASol) is the first and only cyclosporine solution indicated for the treatment of signs and symptoms of dry eye disease with efficacy demonstrated after 4 weeks of treatment.

This press release features multimedia. View the full release here:

Novaliq Announces FDA Approval of VEVYE (Cyclosporine Ophthalmic Solution) 0.1%, for the Treatment of the Signs and Symptoms of Dry Eye Disease (Photo: Business Wire)

"We are proud that FDA approved VEVYE. The safety and efficacy of VEVYE were assessed in a total of 1369 patients with dry eye disease, of which 738 received VEVYE. VEVYE and its novel vehicle were safe, well tolerated, and demonstrated early, consistent, and durable therapeutic effects," said Sonja Krsser, PhD, Vice President Medical Science & Regulatory Affairs at Novaliq. "It is an exciting moment when you have followed science that finally led into a new category of water-free ocular therapies addressing unmet medical needs for patients suffering from dry eye disease."

Continue read on

(RTTNews) - Liquidia Corporation (LQDA) announced today that the U.S. Food and Drug Administration (FDA) accepted for review the company's amendment to the...
Logo NasdaqNasdaq
2023-09-25 21:06:21  • 1 min
Biopharmaceutical company Appili Therapeutics, Inc. (APLI.TO, APLIF.PK) announced Monday that its manufacturing and commercialization partner, Saptalis...
(RTTNews) - Biopharmaceutical company Theratechnologies Inc. (THTX, TH.TO) announced it has filed a supplemental Biologics License Application (sBLA) for the...
Logo NasdaqNasdaq
2023-09-25 11:21:55  • 1 min
Eisai Co Ltd ESALY ESALF and Biogen Inc BIIB announced that humanized anti-soluble aggregated amyloid-beta (A) monoclonal antibody Leqembi Intravenous...
Logo BenzingaBenzinga
2023-09-25 14:41:44  • 2 mins
Key Points A new study said Merck's widely used antiviral Covid pill can cause mutations in the virus that occasionally spread to other people. But there is...
2023-09-25 18:13:15  • 1 min
ISLAMABAD (AP) Pakistan's health minister said Sunday that an injectable medicine that was causing a severe eye infection and sight loss in diabetic patients...
(RTTNews) - Takeda Pharmaceutical Co. Ltd. (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU [Immune...
Logo NasdaqNasdaq
2023-09-25 13:13:07  • 1 min
(RTTNews) - CytoMed Therapeutics Limited (GDTC) said its exclusively licensed induced pluripotent stem cell-based technology has been granted a patent by the...
Logo NasdaqNasdaq
2023-09-25 11:20:44  • 1 min
(RTTNews) - Clene Inc. (CLNN), a unit of Clene Nanomedicine Inc., Monday announced long-term follow-up data showing significant long-term survival...
Logo NasdaqNasdaq
2023-09-25 12:05:06  • 1 min
Novartis AG NVS confirmed its plans for a 100% spin-off of the Sandoz business on October 4 after shareholders approved it earlier this month. Novartis also...
Logo BenzingaBenzinga
2023-09-25 14:38:57  • 1 min
(RTTNews) - AbbVie (ABBV) and Genmab A/S (GMAB) announced Monday that the European Commission has granted conditional marketing authorization for TEPKINLY...
Logo NasdaqNasdaq
2023-09-25 12:50:51  • 1 min
Four in 10 Brits are turning a blind eye to potentially serious eye problems, as many think their sight is good enough to get by. Research which looked at...
Logo The IndependentThe Independent
2023-09-25 06:05:08  • 1 min
An antiviral drug used to treat patients with Covid-19 may be causing mutations in the virus and fuelling the evolution of new variants, scientists have...
Logo The GuardianThe Guardian
2023-09-25 15:00:31  • 1 min
Novartis AG NVS released topline data from the Phase 3 NETTER-2 trial with Lutathera, a radioligand therapy (RLT) for advanced gastroenteropancreatic...
Logo BenzingaBenzinga
2023-09-25 11:14:42  • 1 min
We spend a lot on over-the-counter cold and flu remedies more than 250 million a year in the UK alone to tackle the misery of blocked noses, tickly coughs...
Logo Daily MailDaily Mail
2023-09-25 20:42:37  • 1 min
WASHINGTON The Food and Drug Administration meets this week to consider approval of an experimental treatment for Lou Gehrigs disease, the culmination of a...
2023-09-25 13:49:04  • 1 min
Antibiotics widely used to treat skin and eye infections could ease the pain of endometriosis. Researchers in Japan have found that a type of bacteria called...
Logo Daily MailDaily Mail
2023-09-25 20:43:44  • 1 min
Health care stocks were higher late Monday afternoon with the NYSE Health Care Index rising 0.2% and the Health Care Select Sector SPDR Fund (XLV) up 0.3%....
Logo NasdaqNasdaq
2023-09-25 19:44:33  • 1 min
FDA is the 800-pound gorilla here, and if theyre convinced that the drug doesnt work, its very hard to change their minds, a former FDA official said.
Logo FortuneFortune
2023-09-25 19:56:49  • 1 min
Fintel reports that on September 25, 2023, Craig-Hallum maintained coverage of VIZIO Holding Corp - ( NYSE:VZIO ) with a Buy recommendation. Analyst Price...
Logo NasdaqNasdaq
2023-09-26 03:27:14  • 1 min